Home Search Watchlist Advertise Feedback Profile



Neuren Pharmaceuticals and Acadia Partner to Expand Global License for Trofinetide (DAYBUE™) — ASX:NEU| ASX Mining News & Discussion
L
Lykeshares Official
$NEU Neuren Pharmaceuticals and Acadia Partner to Expand Global License for Trofinetide (DAYBUE™)
Neuren Pharmaceuticals (ASX: NEU) has announced the expansion of its partnership with Acadia Pharmaceuticals (NASDAQ: ACAD) for trofinetide, marketed in the US by Acadia as DAYBUE™. An exclusive license previously granted to Acadia for trofinetide in North America has been expanded to a worldwide exclusive license, with Neuren set to receive an upfront payment of US$100 million, and additional potential milestone payments of up to US$427 million and royalties on net sales of trofinetide outside North America.

Under the expanded partnership, academics' unique expertise from the successful development and commercialisation of trofinetide in the US will facilitate the drug's worldwide development and remove existing limitations for Neuren's NNZ-2591 usage in Rett and Fragile X syndromes. In these two indications, Neuren has granted Acadia an exclusive worldwide license to develop and commercialise NNZ-2591.

Meanwhile, Neuren retains worldwide rights to NNZ-2591 in all other indications and is advancing Phase 2 trials in Phelan-McDermid, Pitt ...
Neuren Pharmaceuticals and Acadia Partner to Expand Global License for Trofinetide (DAYBUE™)

L
Lykeshares Official
Berkshire is hoarding so. much. cash.
Berkshire is hoarding so. much. cash.
L
Lykeshares Official
Intel’s been lagging behind for years, while AMD has pulled far ahead in both consumer and professional-grade chips, it’s really not a close race anymore.

There’s this idea floating around that throwing enough cash at Intel will suddenly turn them into the next TSMC. But semiconductor manufacturing isn’t something you can ...
Intel’s been lagging behind for years, while AMD has pulled far ahead in both consumer and professional-grade chips, it’s really not a close race anymore. There’s this idea floating around that throwing enough cash at Intel will suddenly turn them into the next TSMC. But semiconductor manufacturing isn’t something you can rush, it’s a complex, slow-moving process that takes years of precision and experience. Intel could recover some ground eventually, but framing them as the savior of American chipmaking feels more like a political talking point than a practical reality.
L
Lykeshares Official
Buffet indicator is showing some wild times ahead perhaps, combine that with Berkshires record high cash hoard of 30%... chart via barchart.com / Longtermtrends
Buffet indicator is showing some wild times ahead perhaps, combine that with Berkshires record high cash hoard of 30%... chart via barchart.com / Longtermtrends
L
Lykeshares Official
Looks like we're going through something, but who would have thought with all these tarrifs, inflation and trade wars going on
Looks like we're going through something, but who would have thought with all these tarrifs, inflation and trade wars going on
L
Lykeshares Official
Where does this end up long term with small stocks suffering white giant caps are taking all the coin?
Where does this end up long term with small stocks suffering white giant caps are taking all the coin?
L
Lykeshares Official
🔺 Student Loan Delinquencies Hit Record 12.9%...
The spike in red reflects financial strain returning fast. Credit card delinquencies are rising too, hinting that lower-income consumers might be nearing a breaking point. What's going on...
🔺 Student Loan Delinquencies Hit Record 12.9%... The spike in red reflects financial strain returning fast. Credit card delinquencies are rising too, hinting that lower-income consumers might be nearing a breaking point. What's going on...
L
Lykeshares Official
$ASN Is Anson Resources’ US$330M Financing Deal the Key to Unlocking Utah’s Lithium Potential?
Is Anson Resources’ US$330M Financing Deal the Key to Unlocking Utah’s Lithium Potential?